A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

NCT06410924 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

NAFLD
NASH

Interventions

DRUG: DD01
DRUG: Placebo

Sponsor

Neuraly, Inc.